Sigmapharm Laboratories, LLC, a privately held specialty pharmaceutical company, develops, manufactures and markets unique Generic and Branded products often unmatched by competitors.
Sigmapharm launches Liothyronine Sodium Tablets, USP under the proprietary name LIOMNY™. Effective on December 1st, 2025, LIOMNY™ will be available for mail order delivery in the United States. To see where you can order LIOMNY™ Tablets, click here.
Sigmapharm relaunches its generic Disulfiram Tablets, USP 250 mg, exclusively under its own label.
Sigmapharm initiates a Voluntary Recall at the Retail Level for its drug product, Sodium Phenylbutyrate Powder, 250 Grams. This recall has been initiated due to the out of-specification (OOS) impurity results obtained during routine quality testing of a stability sample for one lot of Sodium Phenylbutyrate Powder, 250 Grams. This recall is being extended to all other potentially impacted lots as mentioned in the attached Recall letters dated August 13, 2021 and September 21, 2021.